Literature DB >> 4204059

Anderson-Fabry disease: a histopathological study of three cases with observations on the mechanism of production of pain.

P Kahn.   

Abstract

A clinical review and histopathological study of three cases of Anderson-Fabry disease is presented and pathological changes in the central and peripheral nervous systems are reported, in some sites for the first time. These are telangiectatic changes in vessels of the sympathetic ganglia in the vertebral trunk; storage of glycolipid in pigmented cells of the substantia nigra and in anterior horn cells; and degeneration of nerve fibres in the dorsal root entry zone and substantia gelatinosa of the spinal cord. The histopathological findings suggest that in this disease pain is due to involvement of dorsal root ganglion cells with associated axonal degeneration of the small fibres in pathways subserving pain.

Entities:  

Mesh:

Year:  1973        PMID: 4204059      PMCID: PMC1083608          DOI: 10.1136/jnnp.36.6.1053

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  FABRY'S DISEASE: CLASSIFICATION AS A SPHINGOLIPIDOSIS AND PARTIAL CHARACTERIZATION OF A NOVEL GLYCOLIPID.

Authors:  C C SWEELEY; B KLIONSKY
Journal:  J Biol Chem       Date:  1963-09       Impact factor: 5.157

2.  THE NEUROPATHOLOGY OF HEREDITARY DYSTOPIC LIPIDOSIS.

Authors:  A N RAHMAN; R LINDENBERG
Journal:  Arch Neurol       Date:  1963-10

3.  Angiokeratoma corporis diffusum. A clinical study of eight affected families.

Authors:  D WISE; H J WALLACE; E H JELLINEK
Journal:  Q J Med       Date:  1962-04

4.  Angiokeratoma corporis diffusum.

Authors:  H J WALLACE
Journal:  Br J Dermatol       Date:  1958-10       Impact factor: 9.302

5.  Inborn errors of metabolism in neurology (Wilson's disease, Refsum's disease and lipidoses).

Authors:  J N Cumings
Journal:  Proc R Soc Med       Date:  1971-03

6.  Anderson-Fabry disease.

Authors:  H J Wallace
Journal:  Br J Dermatol       Date:  1973-01       Impact factor: 9.302

7.  Fabry's disease. Its ocular manifestations.

Authors:  G L Spaeth; P Frost
Journal:  Arch Ophthalmol       Date:  1965-12

8.  Angiokeratoma corporis diffusum--Fabry's disease.

Authors:  A Colombi; A Kostyal; R Bracher; F Gloor; R Mazzi; H Thölen
Journal:  Helv Med Acta       Date:  1967-12

9.  Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency.

Authors:  R O Brady; A E Gal; R M Bradley; E Martensson; A L Warshaw; L Laster
Journal:  N Engl J Med       Date:  1967-05-25       Impact factor: 91.245

10.  The Genetics of Angiokeratoma Corporis Diffusum (Fabry's Disease) and Its Linkage Relations with the Xg Locus.

Authors:  J M Opitz; F C Stiles; D Wise; R R Race; R Sanger; G R Von Gemmingen; R R Kierland; E G Cross; W P De Groot
Journal:  Am J Hum Genet       Date:  1965-07       Impact factor: 11.025

View more
  20 in total

1.  A survey of the pain experienced by males and females with Fabry disease.

Authors:  Andrea L Gibas; Regan Klatt; Jack Johnson; Joe T R Clarke; Joel Katz
Journal:  Pain Res Manag       Date:  2006       Impact factor: 3.037

2.  Significance of screening for Fabry disease among male dialysis patients.

Authors:  Mayuri Ichinose; Masaaki Nakayama; Toya Ohashi; Yasunori Utsunomiya; Masahisa Kobayashi; Yoshikatsu Eto
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

3.  Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease.

Authors:  R Schiffmann; G J Murray; D Treco; P Daniel; M Sellos-Moura; M Myers; J M Quirk; G C Zirzow; M Borowski; K Loveday; T Anderson; F Gillespie; K L Oliver; N O Jeffries; E Doo; T J Liang; C Kreps; K Gunter; K Frei; K Crutchfield; R F Selden; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

4.  Stroke in Fabry's disease.

Authors:  R P Grewal
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

5.  Fabry's disease on the mechanism of the peripheral nerve involvement.

Authors:  N Fukuhara; M Suzuki; N Fujita; T Tsubaki
Journal:  Acta Neuropathol       Date:  1975-10-27       Impact factor: 17.088

6.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males.

Authors:  K D MacDermot; A Holmes; A H Miners
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

7.  Involvement of dorsal root ganglia in Fabry's disease.

Authors:  N Gadoth; U Sandbank
Journal:  J Med Genet       Date:  1983-08       Impact factor: 6.318

8.  Disease rarity, carrier status, and gender: a triple disadvantage for women with Fabry disease.

Authors:  Andrea L Gibas; Regan Klatt; Jack Johnson; Joe T R Clarke; Joel Katz
Journal:  J Genet Couns       Date:  2008-10-16       Impact factor: 2.537

9.  Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIIB study.

Authors:  F Baehner; C Kampmann; C Whybra; E Miebach; C M Wiethoff; M Beck
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

10.  Anderson-Fabry's disease: neuropathological and neurochemical investigation.

Authors:  F Tagliavini; V Pietrini; F Gemignani; A Lechi; R Pallini; A Federico
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.